UBS Group’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $62.4K | Buy |
7,030
+2,804
| +66% | +$32.8K | ﹤0.01% | 7247 |
|
|
2025
Q4 | $62.9K | Sell |
4,226
-8,456
| -67% | -$147K | ﹤0.01% | 7117 |
|
|
2025
Q3 | $244K | Buy |
12,682
+5,150
| +68% | +$82.2K | ﹤0.01% | 6559 |
|
|
2025
Q2 | $83.7K | Sell |
7,532
-65,276
| -90% | -$574K | ﹤0.01% | 7381 |
|
|
2025
Q1 | $1.02M | Buy |
72,808
+55,692
| +325% | +$872K | ﹤0.01% | 5275 |
|
|
2024
Q4 | $284K | Buy |
17,116
+15,396
| +895% | +$250K | ﹤0.01% | 6230 |
|
|
2024
Q3 | $32.5K | Sell |
1,720
-8,316
| -83% | -$169K | ﹤0.01% | 7088 |
|
|
2024
Q2 | $145K | Buy |
10,036
+4,738
| +89% | +$79K | ﹤0.01% | 5893 |
|
|
2024
Q1 | $82K | Buy |
5,298
+4,895
| +1,215% | +$106K | ﹤0.01% | 6305 |
|
|
2023
Q4 | $11.3K | Sell |
403
-7,904
| -95% | -$208K | ﹤0.01% | 7398 |
|
|
2023
Q3 | $395K | Buy |
8,307
+4,645
| +127% | +$354K | ﹤0.01% | 4843 |
|
|
2023
Q2 | $351K | Sell |
3,662
-1,843
| -33% | -$201K | ﹤0.01% | 5105 |
|
|
2023
Q1 | $624K | Sell |
5,505
-5,557
| -50% | -$601K | ﹤0.01% | 4526 |
|
|
2022
Q4 | $1.24M | Buy |
11,062
+9,273
| +518% | +$1.24M | ﹤0.01% | 3867 |
|
|
2022
Q3 | $229K | Buy |
1,789
+1,608
| +888% | +$165K | ﹤0.01% | 4970 |
|
|
2022
Q2 | $12K | Sell |
181
-4,509
| -96% | -$388K | ﹤0.01% | 7666 |
|
|
2022
Q1 | $668K | Buy |
4,690
+4,457
| +1,913% | +$686K | ﹤0.01% | 4467 |
|
|
2021
Q4 | $39K | Sell |
233
-19,560
| -99% | -$3.11M | ﹤0.01% | 7149 |
|
|
2021
Q3 | $2.75M | Buy |
19,793
+19,394
| +4,861% | +$3.79M | ﹤0.01% | 3284 |
|
|
2021
Q2 | $190K | Sell |
399
-11
| -3% | -$4.64K | ﹤0.01% | 5389 |
|
|
2021
Q1 | $168K | Buy |
410
+320
| +356% | +$147K | ﹤0.01% | 5600 |
|
|
2020
Q4 | $44K | Sell |
90
-360
| -80% | -$211K | ﹤0.01% | 6300 |
|
|
2020
Q3 | $255K | Buy |
450
+415
| +1,186% | +$138K | ﹤0.01% | 4645 |
|
|
2020
Q2 | $3K | Sell |
35
-592
| -94% | -$51.9K | ﹤0.01% | 7546 |
|
|
2020
Q1 | $45K | Sell |
627
-1,391
| -69% | -$93.3K | ﹤0.01% | 5912 |
|
|
2019
Q4 | $139K | Buy |
2,018
+913
| +83% | +$67.7K | ﹤0.01% | 5828 |
|
|
2019
Q3 | $88K | Buy |
1,105
+1,040
| +1,600% | +$68.7K | ﹤0.01% | 5841 |
|
|
2019
Q2 | $4K | Sell |
65
-35
| -35% | -$3.32K | ﹤0.01% | 7457 |
|
|
2019
Q1 | $14K | Sell |
100
-59
| -37% | -$7.19K | ﹤0.01% | 6588 |
|
|
2018
Q4 | $15K | Buy |
159
+119
| +298% | +$16.7K | ﹤0.01% | 6993 |
|
|
2018
Q3 | $6K | Sell |
40
-100
| -71% | -$16.2K | ﹤0.01% | 7408 |
|
|
2018
Q2 | $24K | Buy |
140
+35
| +33% | +$5.72K | ﹤0.01% | 6571 |
|
|
2018
Q1 | $15K | Sell |
105
-25
| -19% | -$4.79K | ﹤0.01% | 6616 |
|
|
2017
Q4 | $26K | Hold |
130
| – | – | ﹤0.01% | 6354 |
|
|
2017
Q3 | $42K | Sell |
130
-124
| -49% | -$33.9K | ﹤0.01% | 5912 |
|
|
2017
Q2 | $57K | Sell |
254
-13
| -5% | -$2.67K | ﹤0.01% | 5558 |
|
|
2017
Q1 | $60K | Buy |
267
+112
| +72% | +$22.7K | ﹤0.01% | 5387 |
|
|
2016
Q4 | $31K | Sell |
155
-45
| -23% | -$9.81K | ﹤0.01% | 6208 |
|
|
2016
Q3 | $49K | Buy |
200
+112
| +127% | +$39.3K | ﹤0.01% | 5536 |
|
|
2016
Q2 | $51K | Sell |
88
-6
| -6% | -$3.52K | ﹤0.01% | 5507 |
|
|
2016
Q1 | $50K | Buy |
94
+41
| +77% | +$21.4K | ﹤0.01% | 5512 |
|
|
2015
Q4 | $38K | Buy |
+53
| New | +$34.8K | ﹤0.01% | 6084 |
|
Other funds holding MCRB
FP
VCM
VFT
